Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001)

NCT04375761 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT04375761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
May 1, 2020
Completion date
March 29, 2021
Enrollment
5,599 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19), sars-cov-2